One must learn from mistakes... I hope they do not make the same mistake again. The value statement behind their business is solid but, being doctors, scientists etc. that they are, they rely too much on shareholders having empathy.... which they do not
I agree with previous posts that BOT will definitely come back as soon as someone with business delivery acumen explains to them the correct value added reporting processes to their shareholders.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-82
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |